Cargando…

Angiomotin mutation causes glomerulopathy and renal cysts by upregulating hepatocyte nuclear factor transcriptional activity

Detalles Bibliográficos
Autores principales:	Zhang, Yaochun, Lu, Liangjian, Hu, Zhenhua, Dai, Yu, Ahmad, Nurul Jannah Binti, Ng, Jun Li, Chan, Chang Yien, Hossain, Md. Zakir, Loh, Alwin Hwai Liang, Ward, Jerrold M., Tan, Puay Hoon, Davila, Sonia, Kumar, Vikrant, Hunziker, Walter, Lin, Haishu, Yap, Hui Kim, Ng, Kar Hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9191868/ https://www.ncbi.nlm.nih.gov/pubmed/35696543 http://dx.doi.org/10.1002/ctm2.904

Ejemplares similares

Angiomotin and angiomotin like proteins, their expression and correlation with angiogenesis and clinical outcome in human breast cancer
por: Jiang, Wen G, et al.
Publicado: (2006)

Angiomotin-p130 inhibits β-catenin stability by competing with Axin for binding to tankyrase in breast cancer
por: Yang, Jiao, et al.
Publicado: (2019)

Angiomotin functions in HIV-1 assembly and budding
por: Mercenne, Gaelle, et al.
Publicado: (2015)

Angiomotin Family Members: Oncogenes or Tumor Suppressors?
por: Lv, Meng, et al.
Publicado: (2017)

Hold That Line: Angiomotin Regulates Endothelial Cell Motility
por: Zetter, Bruce R.
Publicado: (2001)

Hippo Pathway-independent Restriction of TAZ and YAP by Angiomotin
por: Chan, Siew Wee, et al.
Publicado: (2011)

Angiomotins link F-actin architecture to Hippo pathway signaling
por: Mana-Capelli, Sebastian, et al.
Publicado: (2014)

Early prediction of revascularisation by angiomotin-targeting positron emission tomography
por: Moyon, Anais, et al.
Publicado: (2018)

Regulation of localization and function of the transcriptional co-activator YAP by angiomotin
por: Moleirinho, Susana, et al.
Publicado: (2017)

Identification of Specific Lysines and Arginines That Mediate Angiomotin Membrane Association
por: Hall, Le’Celia, et al.
Publicado: (2019)

The role of angiomotin phosphorylation in the Hippo pathway during preimplantation mouse development
por: Hirate, Yoshikazu, et al.
Publicado: (2014)

Angiomotin binding-induced activation of Merlin/NF2 in the Hippo pathway
por: Li, Youjun, et al.
Publicado: (2015)

The polarity protein Angiomotin p130 controls dendritic spine maturation
por: Wigerius, Michael, et al.
Publicado: (2018)

Angiomotin: An Angiostatin Binding Protein That Regulates Endothelial Cell Migration and Tube Formation
por: Troyanovsky, Boris, et al.
Publicado: (2001)

Angiomotin family proteins are novel activators of the LATS2 kinase tumor suppressor
por: Paramasivam, Murugan, et al.
Publicado: (2011)

Angiomotin promotes renal epithelial and carcinoma cell proliferation by retaining the nuclear YAP
por: Lv, Meng, et al.
Publicado: (2016)

Angiomotin links ROCK and YAP signaling in mechanosensitive differentiation of neural stem cells
por: Kang, Phillip H., et al.
Publicado: (2020)

Glomerulopathy
por: Boaz, Noel T, et al.
Publicado: (2021)

Angiomotin regulates prostate cancer cell proliferation by signaling through the Hippo-YAP pathway
por: Zeng, Hao, et al.
Publicado: (2016)

Angiomotin Regulates YAP Localization during Neural Differentiation of Human Pluripotent Stem Cells
por: Zaltsman, Yefim, et al.
Publicado: (2019)

p73 is required for vessel integrity controlling endothelial junctional dynamics through Angiomotin
por: Maeso-Alonso, Laura, et al.
Publicado: (2022)

Fibronectin glomerulopathy
por: Ishimoto, Ikue, et al.
Publicado: (2013)

Collagenofibrotic glomerulopathy
por: Kurien, Anila Abraham, et al.
Publicado: (2015)

Collagenofibrotic Glomerulopathy
por: Reddy, M. H. K., et al.
Publicado: (2017)

Collagenofibrotic Glomerulopathy
por: Miyake, Masato, et al.
Publicado: (2020)

Viral Glomerulopathy
por: Deoliveira, Margaret, et al.
Publicado: (2023)

Angiomotin-Like 1 Links Paramyxovirus M Proteins to NEDD4 Family Ubiquitin Ligases
por: Ray, Greeshma, et al.
Publicado: (2019)

Angiomotin prevents pluripotent lineage differentiation in mouse embryos via Hippo pathway-dependent and -independent mechanisms
por: Leung, Chuen Yan, et al.
Publicado: (2013)

Deubiquitylating enzyme USP9x regulates hippo pathway activity by controlling angiomotin protein turnover
por: Thanh Nguyen, Hung, et al.
Publicado: (2016)

Glomerular C4d Immunoperoxidase in Chronic Antibody-Mediated Rejection and Transplant Glomerulopathy
por: Nankivell, Brian J., et al.
Publicado: (2022)

C3 glomerulopathy
por: Cook, H. Terence
Publicado: (2017)

Autoimmune Thyroiditis and Glomerulopathies
por: Santoro, Domenico, et al.
Publicado: (2017)

Infections and Collapsing Glomerulopathy
por: Moktefi, Anissa, et al.
Publicado: (2020)

Use of rituximab in glomerulopathies
por: Dias, Cristiane Bitencourt, et al.
Publicado: (2022)

YAP1 Recruits c-Abl to Protect Angiomotin-Like 1 from Nedd4-Mediated Degradation
por: Skouloudaki, Kassiani, et al.
Publicado: (2012)

The first case of lipoprotein glomerulopathy complicated with collagen type III glomerulopathy and literature review
por: Liu, Huixia, et al.
Publicado: (2022)

Immune checkpoint inhibitor-induced acute tubulointerstitial nephritis
por: Tan, Hui Zhuan, et al.
Publicado: (2022)

Decreased DACH1 expression in glomerulopathy is associated with disease progression and severity
por: Liu, Qing-Quan, et al.
Publicado: (2016)

Schistosoma hematobium-associated glomerulopathy
por: Seck, S. M., et al.
Publicado: (2011)

Collapsing glomerulopathy: The Indian scenario
por: Malhotra, K. P., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_d0le2nblm6av3hlehqm42fn7oa